Filing Details

Accession Number:
0001209191-20-024292
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-04-13 21:06:54
Reporting Period:
2020-04-09
Accepted Time:
2020-04-13 21:06:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1442836 Mersana Therapeutics Inc. MRSN Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1559827 Jr. A. Anthony Florence 5425 Wisconsin Avenue, Suite 800
Chevy Chase MD 20815
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-04-09 4,000,000 $0.00 7,959,520 No 4 J Indirect See Note 2
Common Stock Acquisiton 2020-04-09 40,000 $0.00 40,000 No 4 J Indirect See Note 4
Common Stock Disposition 2020-04-09 40,000 $0.00 0 No 4 J Indirect See Note 4
Common Stock Acquisiton 2020-04-09 20,000 $0.00 20,000 No 4 J Indirect See Note 7
Common Stock Disposition 2020-04-09 20,000 $0.00 0 No 4 J Indirect See Note 7
Common Stock Acquisiton 2020-04-09 77 $0.00 77 No 4 J Indirect See Note 10
Common Stock Acquisiton 2020-04-09 12,054 $0.00 12,131 No 4 J Indirect See Note 10
Common Stock Acquisiton 2020-04-09 2,135 $0.00 2,135 No 4 J Direct
Common Stock Acquisiton 2020-04-09 8,783 $0.00 20,914 No 4 J Indirect See Note 10
Common Stock Disposition 2020-04-13 20,914 $8.50 0 No 4 S Indirect See Note 10
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 J Indirect See Note 2
No 4 J Indirect See Note 4
No 4 J Indirect See Note 4
No 4 J Indirect See Note 7
No 4 J Indirect See Note 7
No 4 J Indirect See Note 10
No 4 J Indirect See Note 10
No 4 J Direct
No 4 J Indirect See Note 10
No 4 S Indirect See Note 10
Footnotes
  1. New Enterprise Associates 14, L.P. ("NEA 14") made a pro rata distribution for no consideration of an aggregate of 4,000,000 shares of Common Stock of the Issuer to its general partner and its limited partners on April 9, 2020.
  2. The Reporting Person is a director of NEA 14 GP, LTD ("NEA 14 LTD"), which is the sole general partner of NEA Partners 14, L.P. ("NEA Partners 14"). NEA Partners 14 is the sole general partner of NEA 14, which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 14 shares in which the Reporting Person has no pecuniary interest.
  3. NEA Partners 14 received 40,000 shares of Common Stock of the Issuer in the distribution by NEA 14 on April 9, 2020.
  4. The Reporting Person is a director of NEA 14 LTD, which is the sole general partner of NEA Partners 14, the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA Partners 14 shares in which the Reporting Person has no pecuniary interest.
  5. NEA Partners 14 made a pro rata distribution for no consideration of an aggregate of 40,000 shares of Common Stock of the Issuer to its limited partners on April 9, 2020.
  6. NEA 14 Manager Fund, L.P. ("NEA 14 Manager Fund") received 20,000 shares of Common Stock of the Issuer in the distribution by NEA 14 on April 9, 2020.
  7. The Reporting Person is a director of NEA 14 LTD, which is the sole general partner of NEA 14 Manager Fund. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities of the Issuer held by NEA 14 Manager Fund in which the Reporting Person has no pecuniary interest.
  8. NEA 14 Manager Fund made a pro rata distribution for no consideration of an aggregate of 20,000 shares of Common Stock of the Issuer to its limited partners on April 9, 2020.
  9. New Enterprise Associates, LLC ("NEA LLC") received 77 shares of Common Stock of the Issuer in the distribution by NEA 14 on April 9, 2020.
  10. The Reporting Person is a member of the Board of Directors of NEA LLC, which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares of the Issuer held by NEA LLC in which the Reporting Person has no pecuniary interest.
  11. NEA LLC received 12,054 shares of Common Stock of the Issuer in the distribution by NEA Partners 14 on April 9, 2020.
  12. The Reporting Person received 2,135 shares of Common Stock of the Issuer in the distribution by NEA Partners 14 on April 9, 2020.
  13. NEA LLC received 8,783 shares of Common Stock of the Issuer in the distribution by NEA 14 Manager Fund on April 9, 2020.
  14. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.44 to $8.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (14) to this Form 4.